propos
cholesterol
host
cell
membran
play
pivot
role
cell
entri
hiv
howev
remain
larg
unknown
virion
prefer
cholesterolrich
heterogen
membran
uniformli
fluid
membran
membran
fusion
use
giant
plasma
membran
vesicl
contain
cholesterolrich
order
cholesterolpoor
fluid
lipid
domain
demonstr
hiv
receptor
substanti
sequest
order
domain
wherea
coreceptor
local
preferenti
ordereddisord
domain
boundari
also
show
hiv
fuse
within
order
region
plasma
membran
rather
boundari
ordereddisord
lipid
domain
coexist
requir
hiv
attach
prerequisit
success
fusion
propos
hiv
virion
sens
exploit
membran
discontinu
gain
entri
cell
studi
provid
surpris
answer
longstand
question
role
cholesterol
order
lipid
domain
cell
entri
hiv
perhap
envelop
virus
cell
membran
consist
numer
protein
lipid
exhibit
complex
behavior
includ
organ
dynam
nanodomain
enrich
sphingolipid
cholesterol
sometim
refer
lipid
raft
accumul
evid
indic
membran
domain
organ
play
vital
role
cell
signal
adapt
immun
respons
combat
infect
mani
pathogen
exampl
hiv
evolv
exploit
organ
membran
domain
gain
entri
host
cell
well
establish
recognit
attach
hiv
host
cell
mediat
bind
viral
envelop
glycoprotein
cellsurfac
receptor
coreceptor
attach
membran
fusion
mediat
subunit
envelop
glycoprotein
lead
cell
entri
found
associ
detergentresist
fraction
cell
membran
assum
cholesteroland
sphingomyelinrich
raft
platform
hiv
entri
howev
lipid
cholesterolrich
region
tightli
pack
order
surround
membran
site
may
seem
energet
unfavor
membran
fusion
therebi
rais
doubt
involv
order
lipid
region
fusion
step
hiv
entri
order
lipid
domain
thought
dynam
fluctuat
nanoscop
assembl
lipid
resid
protein
live
cell
visual
potenti
involv
membran
region
upon
entri
viral
particl
intact
cell
remain
technic
challeng
first
step
toward
solv
problem
show
recent
model
membran
coexist
microscop
order
fluid
lipid
domain
use
prove
fusion
peptid
interact
preferenti
ordereddisord
lipid
domain
boundari
boundari
also
prefer
site
fusion
peptidemedi
membran
fusion
howev
discoveri
rais
import
question
whether
result
obtain
highli
artifici
model
system
could
translat
biolog
membran
contain
hiv
receptor
coreceptor
viru
particl
bear
full
trimer
complex
whether
membran
domain
boundari
would
still
prefer
site
viru
attach
andor
membran
fusion
plasma
membran
appropri
target
cell
therefor
develop
new
approach
measur
bind
fusion
hiv
particl
plasma
membran
assess
role
membran
heterogen
process
use
giant
plasma
membran
vesicl
gpmv
deriv
hela
cell
stabli
express
receptor
coreceptor
investig
later
partit
receptor
membran
imag
prefer
region
hiv
bind
fusion
singleparticl
level
fig
gpmv
show
temperaturedepend
micrometerscal
liquidorderedliquiddisord
lold
phase
separ
extrem
use
studi
dynam
later
distribut
resid
membran
protein
use
approach
found
lipid
order
discontinu
heterogen
receptorand
coreceptorcontain
plasma
membran
import
receptorcoreceptor
target
membran
fusion
number
studi
conduct
local
lymphocyt
cell
membran
although
associ
lipid
raft
gener
accept
diverg
conclus
reach
regard
raft
local
confirm
previou
result
observ
immunofluoresc
coloc
raftresid
gangliosid
hela
cell
wherea
coloc
partial
fig
prepar
gpmv
hela
cell
gentl
formaldehyd
dithiothreitol
dtt
treatment
movi
fig
b
form
membran
bleb
releas
otherwis
intact
cell
membran
cytoskeleton
found
gpmv
show
microscop
lold
phase
separ
movi
fig
c
e
expect
immunostain
intact
cell
substanti
exclud
ld
region
gpmv
indic
partit
lo
region
fig
b
c
preferenti
local
boundari
lo
ld
phase
occur
evid
cellattach
bleb
celldetach
gpmv
fig
b
c
result
might
explain
debat
controversi
associ
lipid
raft
associ
lo
ld
lipid
phase
accumul
boundari
similar
result
obtain
altern
procedur
induc
membran
bleb
applic
small
concentr
nethylmaleimid
nem
fig
suggest
result
independ
bleb
agent
result
gpmv
seriou
membran
defect
recognit
lold
membran
boundari
hiv
next
examin
whether
hiv
envelop
env
particl
interact
gpmv
murin
leukemia
virus
mlv
pseudotyp
hiv
fluoresc
label
mkogag
incub
gpmv
visual
bound
particl
epifluoresc
microscopi
found
migrat
along
prepar
largescal
phasesepar
gpmv
facilit
studi
later
distribut
role
order
lipid
domain
hiv
entri
lo
ld
phase
gpmv
indic
red
blue
line
respect
b
c
partit
cellattach
b
celldetach
c
gpmv
gpmv
first
stain
perchlor
dii
min
incub
fluorescentlabel
ctxb
alexa
fluor
alexa
fluor
alexa
fluor
antibodi
min
epifluoresc
imag
gpmv
perform
room
temperatur
show
largescal
lold
phase
coexist
dii
ctxb
use
marker
ld
lo
phase
respect
select
rectangl
enlarg
shown
hiv
bind
cellattach
gpmv
cellattach
gpmv
left
virus
label
mkogag
center
visual
brightfield
epifluoresc
microscopi
respect
imag
overlay
right
show
bright
dot
hiv
env
particl
indic
arrow
sit
gpmv
surfac
top
time
seri
imag
select
box
region
show
particl
bound
gpmv
free
move
later
along
gpmv
surfac
bottom
movi
version
figur
avail
movi
e
f
hiv
bind
boundari
lo
ld
phase
cellattach
e
celldetach
f
gpmv
gpmv
left
hiv
env
particl
center
label
dio
mkogag
respect
g
quantif
virion
bound
three
differ
region
lo
ld
lold
boundari
gpmv
data
mean
sd
triplic
total
virion
analyz
distribut
three
compart
largest
fraction
virion
found
lold
boundari
region
scale
bar
mm
gpmv
surfac
fig
movi
stain
gpmv
ld
marker
perchlor
dio
show
bound
particl
local
lold
boundari
region
cellattach
fig
movi
fig
celldetach
gpmv
fig
movi
quantifi
virion
bound
three
differ
region
lo
ld
lold
boundari
shown
fig
assess
whether
target
virion
lold
interfac
specif
hiv
env
also
perform
similar
experi
mlv
pseudotyp
env
g
protein
glycoprotein
vesicular
stomat
viru
vsvg
vsvg
virion
preferenti
bound
ld
phase
gpmv
fig
indic
lold
boundari
interact
gener
featur
viral
particl
requir
hiv
env
given
initi
local
lo
phase
region
membran
seem
reason
propos
hiv
virion
bind
lo
phase
membran
region
move
domain
boundari
also
engag
bind
preferenti
target
fusion
peptid
lipid
phase
boundari
like
combin
direct
particl
fusion
boundari
determin
whether
hiv
env
particl
inde
fuse
gpmv
lipid
phase
boundari
first
examin
whether
fuse
gpmv
bulk
lipid
mix
assay
virion
label
selfquench
concentr
fluoresc
lipid
probe
mix
unlabel
gpmv
lipid
mix
observ
gpmv
contain
neglig
gpmv
deriv
hela
cell
lack
receptor
coreceptor
fig
demonstr
specif
hivgpmv
fusion
system
found
lipid
mix
strongli
suppress
wellknown
hiv
entri
inhibitor
maraviroc
enfuvirtid
fig
maraviroc
inhibit
bind
coreceptor
enfuvirtid
inhibit
fusion
block
requir
conform
chang
maraviroc
reduc
target
hiv
virion
phase
boundari
fig
support
notion
recognit
occur
boundari
contrast
enfuvirtid
littl
effect
boundari
prefer
hiv
bind
still
block
fusion
fig
suggest
boundari
bind
alon
suffici
fusion
requir
energi
refold
sixhelix
bundl
structur
well
also
observ
fusion
gpmv
singleparticl
level
fluoresc
mani
hiv
env
particl
bound
lold
phase
boundari
spread
time
indic
particl
fuse
gpmv
fig
addit
carri
electron
cryomicroscopi
cryoem
attempt
directli
visual
process
fusion
viral
particl
gpmv
previous
observ
bare
mlv
contain
gag
gagpol
spheric
tenni
racketshap
particl
show
characterist
morpholog
capsid
surround
viral
envelop
fig
repres
electron
micrograph
obtain
four
differ
incub
two
separ
viral
two
separ
gpmv
prepar
show
hiv
env
particl
intim
contact
gpmv
surfac
fig
fig
also
observ
membran
perturb
confin
area
gpmv
lipid
bilay
may
repres
fusion
intermedi
fig
ensur
observ
contact
specif
control
gpmv
lack
mix
hiv
env
particl
fifteen
randomli
select
gpmv
per
grid
imag
three
differ
sampl
virusgpmv
fusion
event
observ
howev
present
resolut
cryoem
imag
permit
distinct
lo
ld
phase
thu
suffici
determin
whether
fusion
occur
lold
phase
boundari
next
examin
whether
lold
phase
coexist
gpmv
requir
hiv
env
particl
bind
andor
fusion
disrupt
lo
phase
domain
treat
gpmv
methylbcyclodextrin
mbcd
deplet
cholesterol
membran
mbcd
treatment
gpmv
led
mark
chang
approxim
circular
lo
domain
corrug
shape
characterist
bilay
gel
phase
fig
movi
howev
cholesterol
extract
significantli
alter
overal
surfac
express
level
gpmv
fig
virion
bind
quantifi
directli
count
number
particl
attach
gpmv
fig
centrifugationbas
assay
fig
regardless
method
particl
bind
high
diminish
cholesterol
deplet
gpmv
indic
presenc
lo
domain
requir
bind
virion
howev
hiv
env
particl
bind
gpmv
lack
confirm
attach
mediat
receptor
rather
lipid
phase
separ
contrari
virion
attach
disrupt
lo
phase
domain
gpmv
mbcd
significantli
decreas
effici
fusion
hiv
env
virion
gpmv
fig
result
agre
previou
report
demonstr
decreas
hiv
cell
entri
deplet
cholesterol
host
cell
membran
inhibitori
effect
fusion
disrupt
lo
phase
lold
phase
boundari
gpmv
suggest
uniqu
properti
boundari
respons
attract
receptor
coreceptor
high
fusogen
hiv
env
virion
site
thu
physic
principl
promot
fusion
peptidemedi
fusion
lipid
model
membran
name
line
tension
lipid
pack
defect
lold
phase
boundari
also
provid
signific
drive
forc
membran
fusion
hiv
env
viral
particl
biolog
membran
lysolipid
adopt
invertedcon
molecular
shape
report
inhibit
fusion
wide
varieti
system
owe
propens
induc
posit
intrins
membran
curvatur
test
whether
lysolipid
affect
lipid
phase
behavior
gpmv
abil
hiv
fuse
lysosphingomyelin
lysosm
partial
dissolv
lo
domain
gpmv
much
smaller
domain
wherea
lysophosphatidylcholin
lysopc
littl
effect
lo
domain
fig
movi
although
lysosm
lysopc
share
cholin
headgroup
similar
molecular
shape
may
differ
affect
line
tension
phase
boundari
lysosm
linact
appear
reduc
line
tension
wherea
lysopc
probabl
partit
uniformli
ld
phase
lesser
effect
line
tension
hiv
env
virion
bind
affect
lysosm
lysopc
fig
howev
lysosm
significantli
reduc
fusion
effici
hiv
particl
wherea
lysopc
moder
effect
fig
togeth
result
support
notion
site
fusion
domain
boundari
region
inhibitori
lysosm
enrich
lysopc
enrich
effect
could
trigger
enzymat
treatment
gpmv
phospholipas
hydrolyz
glycerophospholipid
includ
pc
lysopc
littl
effect
lipid
phase
behavior
gpmv
hiv
fusion
wherea
sphingolipid
ceramid
ndeacylas
scdase
convert
sm
lysosm
dispers
lo
domain
eventu
spread
entir
gpmv
surfac
significantli
inhibit
fusion
fig
c
note
fluoresc
lipid
probe
dii
alway
mark
ld
phase
imag
appar
revers
contrast
imag
due
differ
level
cholesterol
chang
connect
lo
phase
previous
demonstr
model
system
probe
influenc
lysolipid
lipid
phase
hiv
fusion
welldefin
model
membran
use
giant
unilamellar
vesicl
guv
larg
unilamellar
vesicl
luv
compos
bsmbpcbpscholesterol
model
lysosm
significantli
chang
lo
domain
guv
fig
inhibit
fusion
luv
hiv
fusion
peptidedecor
virosom
wherea
lysopc
small
effect
highest
concentr
fig
domain
edg
first
undul
larger
invagin
form
eventu
dispers
domain
much
smaller
one
movi
regul
size
lipid
raft
use
lysosphingolipid
signific
consequ
hiv
entri
also
cell
signal
exampl
well
known
potent
mediat
numer
signal
pathway
find
signal
mechan
could
potenti
raft
regul
may
interest
topic
futur
investig
previous
report
recruit
protein
ra
domain
boundari
may
gener
may
contribut
regul
signal
pathway
regul
natur
size
lipid
raft
system
support
lipid
bilay
gener
synthet
natur
lipid
wide
appli
sinc
origin
introduct
includ
recent
studi
fusion
singl
particl
planar
geometri
support
membran
advantag
guv
larg
extend
membran
observ
total
intern
reflect
fluoresc
tirf
microscopi
therefor
larg
number
singl
event
simultan
record
high
signaltonois
ratio
experi
lead
greatli
improv
statist
exploit
advantag
biolog
membran
well
develop
support
planar
plasma
membran
sppm
singleparticl
fusion
studi
fig
strategi
prepar
sppm
fuse
gpmv
onto
polymersupport
lipid
monolay
transfer
langmuir
trough
differ
previou
method
preferenti
orient
membran
receptor
bind
site
access
solut
similar
plain
support
lipid
bilay
sppm
prepar
fashion
display
micrometers
domain
raft
nonraft
lipid
compon
later
mobil
fig
agreement
observ
gpmv
overlay
imag
sppm
show
substanti
associ
lo
domain
wherea
preferenti
locat
edg
domain
fig
fig
observ
tirf
microscopi
singl
hiv
env
particl
bound
predominantli
domain
boundari
wherea
vsvg
particl
bound
ld
phase
sppm
fig
c
addit
experi
recapitul
observ
made
gpmv
locat
hiv
bind
sppm
determin
primarili
locat
receptor
coreceptor
membran
lipid
phase
fig
observ
larg
number
singlemembran
fusion
event
hiv
env
particl
sppm
fig
movi
classifi
dock
hemifus
full
fusion
fig
lo
ld
lold
compart
sppm
observ
direct
full
fusion
littl
hemifus
ld
phase
direct
full
fusion
hemifus
hiv
virion
lo
phase
domain
fig
contrast
hiv
virion
fuse
effici
particl
lold
domain
boundari
addit
hemifus
locat
fig
result
qualit
similar
quantit
robust
obtain
gpmv
therefor
valid
sppm
use
addit
system
quantit
analyz
fusion
heterogen
biolog
membran
singleparticl
level
membran
fusion
hiv
entri
highli
cooper
process
must
overcom
sever
energi
barrier
associ
differ
fusion
intermedi
energi
must
provid
releas
right
time
right
place
drive
merger
viral
target
membran
although
cholesterolrich
lipid
domain
implic
cell
entri
propos
involv
puzzl
order
lipid
thought
detriment
membran
bend
fusion
howev
recent
discov
lold
phase
boundari
facilit
fusion
model
system
demonstr
line
tension
boundari
might
provid
addit
previous
unrecogn
drive
forc
fusion
previou
work
limit
receptor
coreceptor
present
could
argu
pure
lipid
model
membran
oversimplifi
biolog
membran
overcom
limit
demonstr
work
similar
mechan
govern
hiv
fusion
biolog
host
membran
contain
natur
receptor
directli
observ
lipid
domain
boundari
portal
hiv
bind
membran
fusion
presum
present
weakest
point
host
membran
basi
result
propos
follow
model
hiv
bind
receptor
locat
cholesterolrich
lipid
domain
exist
transient
plasma
membran
live
cell
locat
near
coreceptor
domain
boundari
initi
bind
lead
structur
chang
bind
coreceptor
enrich
bound
virion
boundari
fig
bind
chang
conform
expos
fusion
peptid
lipid
boundari
region
predispos
prefer
membran
domain
boundari
greatli
facilit
target
fusion
peptid
fusionpromot
area
host
membran
although
examin
hiv
coreceptor
studi
might
function
equival
recruit
virion
domain
boundari
region
effici
fusion
receptor
cooper
membran
domain
boundari
form
hiv
entri
site
would
interest
examin
futur
studi
bind
fusion
effici
hiv
particl
gpmv
sppm
distribut
differ
randomli
contrast
mani
envelop
virus
hiv
display
trimer
glycoprotein
spike
envelop
small
number
certainli
ineffici
hiv
entri
fusion
howev
cooper
hiv
recognit
fusion
membran
domain
boundari
may
uniqu
way
overcom
defici
may
provid
enough
energi
drive
fusion
transit
state
low
env
copi
number
model
system
line
tension
boundari
like
serv
addit
drive
forc
fusion
well
known
cell
play
central
role
immun
respons
follow
cell
antigen
receptor
engag
trigger
cell
activ
prolifer
invad
pathogen
cell
activ
elicit
recruit
number
protein
order
lipid
region
result
format
larger
membran
domain
exploit
hiv
facilit
entri
fig
b
c
hiv
exhibit
infect
much
lower
frequenc
cell
activ
cell
suggest
hiv
infect
may
associ
coalesc
cholesterolrich
lipid
domain
model
system
shown
line
tension
may
also
domin
forc
promot
membran
fusion
biolog
membran
boundari
larger
lipid
domain
activ
cell
could
contribut
elev
fusogen
capac
activ
cell
versu
rest
cell
possibl
activ
immun
system
invad
pathogen
make
cell
prone
hiv
entri
describ
mechan
therefor
enhanc
domain
activ
could
lead
elev
product
hiv
peopl
infect
pathogen
thu
acceler
progress
aid
fig
final
work
also
show
gpmv
novel
procedur
produc
support
planar
gpmvderiv
membran
call
sppm
use
studi
select
target
membran
fusion
hiv
virion
anticip
method
also
use
studi
bind
fusion
properti
mani
particl
cellderiv
plasma
membran
new
approach
versatil
lead
mani
new
discoveri
regard
role
lipid
protein
heterogen
cell
membran
may
also
serv
novel
platform
screen
viral
entri
inhibitor
lipid
fluoresc
probe
avanti
polar
lipid
dio
dii
octadecyl
rhodamin
b
chlorid
invitrogen
mbcd
nem
fluorescein
isothiocyan
alexa
alexa
ctxb
purchas
sigmaaldrich
formaldehyd
dtt
purchas
avantor
rpi
respect
alexa
antibodi
alexa
antibodi
purchas
novu
biolog
hiv
entri
inhibitor
maraviroc
enfuvirtid
scdase
purchas
sigmaaldrich
hiv
fusion
peptid
customsynthes
yale
wm
keck
biotechnolog
resourc
laboratori
hiv
pseudoviru
product
hiv
env
particl
pseudotyp
envelop
protein
contain
mlv
core
protein
prepar
cotransfect
cell
mg
pfbluc
mlv
vector
plasmid
mg
packag
construct
mg
mlv
mkogag
mg
hiv
jrfl
env
plasmid
use
polyfect
reagent
qiagen
viruscontain
medium
collect
hour
transfect
centrifug
rpm
min
clear
debri
prepar
didlabel
hiv
particl
medium
replac
optimem
gibco
life
technolog
contain
mm
hour
transfect
hour
incub
unincorpor
dye
remov
wash
cell
return
regular
growth
medium
hour
incub
extracellular
medium
collect
centrifug
low
speed
remov
cell
debri
filter
syring
filter
store
use
control
experi
mlv
pseudotyp
vsvg
mlv
core
protein
also
prepar
bulk
bind
lipid
mix
assay
membran
viral
particl
label
ml
octadecyl
rhodamin
b
chlorid
mgml
ml
viru
min
room
temperatur
free
remov
sephadex
desalt
column
ge
healthcar
infecti
titer
determin
luciferas
assay
previous
describ
hela
cell
hiv
env
pseudotyp
virus
prepar
gpmv
deriv
hela
cell
hela
cell
provid
rekosh
univers
virginia
gpmv
produc
isol
cell
previous
describ
slight
modif
briefli
hela
cell
cultur
iscov
modifi
dulbecco
medium
fetal
bovin
serum
fb
mgml
penicillinstreptomycin
penstrep
puromycin
mgml
incub
co
plain
hela
cell
lack
grown
dulbecco
modifi
eagl
medium
fb
penstrep
incub
grow
cell
confluenc
cultur
dish
cell
wash
three
time
bleb
buffer
mm
hepe
mm
nacl
mm
cacl
ph
membran
vesicul
induc
ad
mm
formaldehyd
mm
dtt
mm
nem
order
membran
domain
rest
cell
plasma
membran
nanoscop
shortliv
small
dynam
domain
coalesc
creat
larger
one
function
signal
platform
upon
pathogen
invas
helper
cell
recogn
pathogenderiv
antigen
surfac
antigenpres
cell
apc
becom
activ
coalesc
membran
domain
activ
cell
stimul
abil
b
cell
cell
defend
invad
pathogen
model
propos
cell
challeng
pathogen
prone
hiv
infect
rest
cell
indic
red
arrow
hiv
infect
lead
apoptot
cell
death
ultim
result
progress
aid
bleb
buffer
hour
follow
shake
solut
contain
celldetach
gpmv
gentli
decant
tube
gpmv
place
ice
min
settl
rel
larg
gpmv
mm
diamet
transfer
bottom
tube
coverslip
observ
epifluoresc
microscop
later
distribut
rel
amount
gpmv
observ
later
distribut
cellattach
isol
gpmv
prepar
cellattach
gpmv
hela
cell
seed
quartz
slide
glass
coverslip
grown
confluenc
induc
gpmv
cell
describ
rins
extens
phosphatebuff
salin
pb
remov
gpmvinduc
chemic
cellattach
gpmv
isol
gpmv
block
bovin
serum
albumin
pb
vesicl
stain
ld
marker
dii
mm
dio
mm
andor
lo
marker
alexa
ctxb
mgml
min
ice
label
gpmv
incub
antibodi
andor
antibodi
conjug
alexa
andor
alexa
respect
concentr
mgml
min
later
distribut
fluoresc
lipid
protein
cell
gpmv
visual
use
epifluoresc
microscop
immunofluoresc
stain
also
use
evalu
amount
surfac
gpmv
quantif
isol
gpmv
incub
antibodi
min
unbound
antibodi
remov
centrifug
min
gpmv
pellet
resuspend
ml
hepe
buffer
rel
amount
measur
room
temperatur
fluoresc
emiss
intens
alexa
nm
alexa
nm
jobinyvon
spectrofluoromet
jobinyvon
excit
wavelength
nm
respect
gpmv
hela
cell
use
neg
control
display
low
neglig
fluoresc
intens
singl
bulk
bind
assay
hiv
env
particl
gpmv
bind
singl
hiv
env
particl
gpmv
gpmv
induc
hela
cell
quartz
glass
slide
stain
dio
nbd
dope
gpmv
rins
buffer
fabric
flowthrough
chamber
hiv
particl
label
mko
mkogag
inject
chamber
contain
cellattach
isol
gpmv
incub
min
bind
particl
gpmv
visual
epifluoresc
microscopi
bind
site
virion
number
virion
bound
gpmv
count
bind
effici
bind
site
vsvg
env
particl
gpmv
also
perform
control
experi
quantifi
bulk
bind
effici
hiv
viral
particl
ad
gpmv
label
tube
nbddope
incub
min
unbound
particl
remov
centrifug
min
pellet
contain
virusbound
gpmv
resuspend
ml
vv
triton
fluoresc
emiss
intens
nm
nbd
nm
record
room
temperatur
jobinyvon
spectrofluoromet
jobinyvon
excit
wavelength
nm
respect
ratio
fluoresc
intens
nm
use
measur
rel
bind
effici
hiv
env
particl
gpmv
fusion
viru
particl
unlabel
gpmv
measur
dequench
fluoresc
unlabel
gpmv
ad
virion
particl
hepe
buffer
room
temperatur
concentr
gpmv
estim
total
protein
concentr
gpmv
use
bicinchonin
acid
assay
protein
concentr
gpmv
deriv
mbcdtreat
plain
hela
cell
mgml
respect
fluoresc
intens
measur
constant
stir
use
spectrofluoromet
jobinyvon
excit
emiss
wavelength
nm
respect
dequench
fluoresc
normal
initi
fluoresc
ff
prepar
sampl
electron
cryomicroscopi
cryoem
hiv
env
particl
incub
gpmv
room
temperatur
captur
earli
stage
membran
fusion
hiv
particl
gpmv
sampl
ml
appli
either
cflat
quantifoil
holey
carbon
grid
manual
blot
near
dryness
filter
paper
rapidli
plung
slurri
liquid
ethan
grid
transfer
liquid
nitrogen
tecnai
cyroem
philipsfei
oper
kv
imag
record
magnif
lowelectron
dose
condit
e
use
chargecoupl
devic
ccd
camera
gatan
cholesterol
deplet
isol
gpmv
hela
cell
incub
mm
mbcd
hepe
buffer
min
room
temperatur
gpmv
incub
mm
lysosm
mm
lysopc
hepe
buffer
min
room
temperatur
examin
effect
lysolipid
lipid
phase
yet
gpmv
ad
u
mm
trishcl
buffer
ph
mu
scdase
mm
sodium
acet
buffer
ph
adjust
osmol
mmolkg
addit
nacl
incub
room
temperatur
min
incub
gpmv
isol
centrifug
min
use
measur
hiv
bind
fusion
fluoresc
imag
record
zeiss
axiovert
fluoresc
microscop
carl
zeiss
mercuri
lamp
light
sourc
water
immers
object
carl
zeiss
numer
apertur
electronmultipli
ccd
cool
ixon
andor
detector
imag
acquir
use
homemad
softwar
written
labview
nation
instrument
membran
stain
dio
nbd
epiillumin
bandpass
filter
chroma
via
dichroic
mirror
chroma
fluoresc
observ
bandpass
filter
chroma
diior
rhodaminestain
membran
mkolabel
viral
particl
epiillumin
bandpass
filter
chroma
via
dichroic
mirror
chroma
fluoresc
observ
bandpass
filter
chroma
viral
particl
luv
stain
illumin
bandpass
filter
chroma
observ
bandpass
filter
chroma
fluoresc
imag
perform
room
temperatur
imag
process
assess
coloc
use
imagej
guv
prepar
via
electroform
techniqu
briefli
ml
mm
lipid
mixtur
compos
bsmbpcbpscholesterol
contain
fluoresc
lipid
probe
rhpe
mole
percent
mol
deposit
conduct
surfac
two
indium
tin
oxideco
glass
slide
slide
place
vacuum
desicc
min
remov
residu
solvent
fabric
chamber
compos
two
conduct
slide
face
separ
spacer
fill
mm
sucros
h
guv
gener
appli
altern
electr
current
v
hz
function
gener
min
transfer
mm
glucos
solut
settl
graviti
microscop
slide
lipid
mix
luv
mediat
hiv
fusion
peptid
luv
prepar
extrus
phospholipid
compos
bsm
bpcbpscholesterol
dissolv
mixtur
chloroform
methanol
solvent
evapor
stream
nitrogen
ga
glass
test
tube
thin
lipid
film
dri
overnight
vacuum
hydrat
ml
hepe
buffer
mm
hepe
mm
nacl
ph
suspens
vigor
vortex
min
subject
freezethaw
cycl
extrud
time
two
stack
polycarbon
filter
pore
size
nm
avestin
lipid
mix
assay
base
fluoresc
reson
energi
transfer
nbdpe
rhodaminep
hiv
fusion
peptid
ad
mm
luv
ratio
label
mol
nbdpe
rhodaminep
unlabel
luv
hepe
buffer
room
temperatur
fluoresc
record
constant
stir
spectrofluoromet
jobinyvon
excit
emiss
wavelength
set
nm
respect
valu
lipid
mix
fluoresc
intens
luv
suspens
fusion
peptid
ad
wherea
valu
lipid
mix
obtain
ad
triton
final
concentr
vv
suspens
end
experi
quartz
slide
clean
boil
contrad
deterg
min
sonic
hot
bath
min
rins
deioniz
water
ethanol
slide
immers
piranha
solut
mixtur
sulfur
acid
hydrogen
peroxid
remov
remain
organ
residu
follow
extens
rins
pure
water
first
leaflet
sppm
prepar
langmuirblodgett
lb
transfer
directli
onto
quartz
slide
lipid
mixtur
compos
bsm
bpccholesterol
mol
dmpe
polyethyleneglycoltriethoxysilan
spread
onto
pure
water
surfac
nima
lb
trough
ksv
nima
allow
solvent
evapor
min
monolay
compress
rate
cm
min
reach
surfac
pressur
mnm
immedi
use
quartz
slide
clean
min
argon
plasma
steril
harrick
scientif
dip
trough
speed
mmmin
withdrawn
mmmin
keep
monolay
surfac
pressur
constant
mnm
transfer
lipid
monolay
dri
vacuum
desicc
room
temperatur
overnight
cure
oven
min
coval
link
polym
sio
slide
surfac
equilibr
desicc
room
temperatur
slide
tether
polymersupport
lb
monolay
place
custombuilt
flowthrough
chamber
suspens
gpmv
hepe
buffer
inject
chamber
incub
least
hour
room
temperatur
form
distal
leaflet
sppm
bilay
excess
unfus
gpmv
wash
extens
rins
hepe
buffer
integr
sppm
diffus
lipid
within
examin
fluoresc
recoveri
photobleach
frap
bilay
bleach
pattern
parallel
stripe
data
fit
model
f
f
f
f
exp
f
f
initi
final
fluoresc
intens
bleach
respect
p
stripe
period
mm
later
diffus
coeffici
mobil
fraction
mf
reflect
percentag
observ
fluoresc
recoveri
within
time
frame
frap
experi
min
given
mf
f
pre
f
pre
fluoresc
intens
photobleach
ten
region
three
independ
prepar
bilay
sampl
determin
report
averag
valu
bind
fusion
singl
hiv
env
particl
sppm
tirf
microscopi
measur
bind
sppm
mkolabel
mkogag
hiv
env
particl
inject
chamber
unlabel
sppm
fluoresc
increas
hiv
bind
sppm
monitor
time
prismbas
tirf
microscopi
prismquartz
interfac
lubric
glycerol
allow
easi
transloc
sampl
cell
microscop
stage
light
sourc
argon
ion
laser
innova
coher
emit
light
nm
fluoresc
observ
bandpass
filter
chroma
beam
total
intern
reflect
angl
normal
produc
evanesc
wave
intens
laser
beam
computercontrol
acoustoopt
modul
isomet
could
block
entir
computercontrol
shutter
laser
intens
shutter
camera
control
homemad
program
written
labview
nation
instrument
investig
target
hiv
particl
differ
region
ldlo
phasesepar
sppm
mkolabel
particl
incub
sppm
stain
dio
min
room
temperatur
unbound
particl
wash
away
hepe
buffer
phasesepar
sppm
visual
epifluoresc
microscopi
bound
particl
visual
tirf
microscopi
analyz
quantifi
distribut
sppmbound
particl
distinguish
three
region
sppm
lo
domain
ld
phase
area
lold
boundari
region
width
center
perimet
lo
domain
custombuilt
particletrack
softwar
use
automat
detect
posit
x
coordin
particl
monitor
fusion
singl
hiv
particl
sppm
didlabel
hiv
env
particl
inject
chamber
one
larg
window
wall
form
sppm
light
sourc
tirf
illumin
diod
laser
coher
excit
lipid
dye
filter
chroma
via
dichroic
mirror
chroma
fluoresc
observ
bandpass
filter
chroma
data
acquisit
imag
analysi
accomplish
custombuilt
softwar
written
labview
nation
instrument
singl
event
includ
dock
hemifus
full
fusion
measur
analyz
peak
fluoresc
intens
bound
particl
function
time
event
fluoresc
chang
time
classifi
dock
decay
around
onehalf
origin
peak
intens
classifi
hemifus
complet
decay
classifi
direct
full
fusion
event
supplementari
materi
articl
avail
http
advancessciencemagorgcgi
fig
associ
lipid
raft
hela
cell
stabli
express
fig
format
gpmv
treatment
hela
cell
small
amount
formaldehyd
dtt
fig
partit
gpmv
induc
nem
instead
formaldehyd
dtt
cell
fig
hiv
env
pseudoviru
particl
bind
preferenti
boundari
coexist
lo
ld
domain
gpmv
fig
vsvg
pseudoviru
particl
bind
ld
membran
region
gpmv
fig
electron
cryomicrograph
hiv
env
particl
boundfus
gpmv
fig
modul
lipid
phase
affect
bind
hiv
gpmv
fig
prepar
sppm
gpmv
fig
later
distribut
sppm
movi
grow
gpmv
cell
surfac
